SPOTLIGHT -
BRIO-1 study results show renewed hope for medical presbyopia correction
Results of the BRIO-I study, the first of 2 phase 3 clinical trials of Brimochol PF, a topical, fixed-dose combination for the treatment of presbyopia, have recently been released.
Inaugural IKA symposium shines a light on diagnosing and managing keratoconus
Cochair Elizabeth Yeu, MD, highlights what this program will mean for ophthalmologists, optometrists, and their patients.
International Keratoconus Academy continues to provide cutting-edge education
Over the years, IKA has become an invaluable resource for eye care professionals.